CHICAGO, June 11, 2013 /PRNewswire/ -- JBT
Corporation (NYSE: JBT) today announced it received an
$8 million order from Ohio State University Wexner Medical Center for the
supply and integration of automatic guided vehicle (AGV) products
and services.
This order includes both upgrading the existing fleet of AGVs at
the medical center and delivering additional AGVs to support
operations at the new James Cancer Hospital and Solove Research
Institute and Critical Care Center.
"This medical center has been a valued JBT customer for over a
decade and we are happy to continue this strong relationship with
such a respected leader in the health care industry," stated
John Lee, Vice President of JBT
AeroTech.
All automated systems will be commissioned by the end of
2014.
About JBT Corporation
JBT Corporation (NYSE:JBT) is a leading global solutions
provider to the food processing and air transportation industries.
JBT Corporation designs, manufactures, tests and services
technologically sophisticated systems and products for regional and
multi-national industrial food processing customers through its JBT
FoodTech segment and for domestic and international air
transportation customers through its JBT AeroTech segment. JBT
Corporation employs approximately 3,200 people worldwide and
operates sales, service, manufacturing and sourcing operations
located in over 25 countries. For more information please visit
www.jbtcorporation.com or
http://www.jbtc-agv.com.
This release contains forward-looking statements as defined
in the Private Securities Litigation Reform Act of 1995.
Forward-looking statements are information of a non-historical
nature and are subject to risks and uncertainties that are beyond
the Company's ability to control. These risks and uncertainties are
described under the caption "Risk Factors" in the Company's Annual
Report on Form 10-K filed by the Company with the Securities and
Exchange Commission that may be accessed on the Company's website.
The Company cautions shareholders and prospective investors that
actual results may differ materially from those indicated by the
forward-looking statements.
SOURCE JBT Corporation